KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NovoCure (NVCR) Accumulated Expenses (2016 - 2018)

NovoCure (NVCR) has disclosed Accumulated Expenses for 5 consecutive years, with $16.7 million as the latest value for Q4 2018.

  • Quarterly Accumulated Expenses rose 25.85% to $16.7 million in Q4 2018 from the year-ago period, while the trailing twelve-month figure was $16.7 million through Dec 2018, up 25.85% year-over-year, with the annual reading at $16.7 million for FY2018, 25.85% up from the prior year.
  • Accumulated Expenses hit $16.7 million in Q4 2018 for NovoCure, up from $13.3 million in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $16.7 million in Q4 2018 to a low of $5.8 million in Q4 2014.
  • Historically, Accumulated Expenses has averaged $10.3 million across 5 years, with a median of $8.3 million in 2015.
  • Biggest five-year swings in Accumulated Expenses: fell 8.68% in 2016 and later surged 76.14% in 2017.
  • Year by year, Accumulated Expenses stood at $5.8 million in 2014, then surged by 41.26% to $8.3 million in 2015, then dropped by 8.68% to $7.5 million in 2016, then soared by 76.14% to $13.3 million in 2017, then increased by 25.85% to $16.7 million in 2018.
  • Business Quant data shows Accumulated Expenses for NVCR at $16.7 million in Q4 2018, $13.3 million in Q4 2017, and $7.5 million in Q4 2016.